Bruce Booth sold $21.5M of Kymera Therapeutics (KYMR)

Executed Dec 10 2025, disclosed Dec 12 2025, 2 days later.

Value, as filed

$21.5M

234,934 sh across 11 lots

Executed

Dec 10 2025

the trade date, as filed

Disclosed

Dec 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Bruce Booth Director profile →

Bruce Booth (Director) filed 16 Form 4 reports in the trailing twelve months (0 purchases, 16 sales, 1 filed past the two-business-day deadline), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $56.3M of KYMR (511,764 sh across 27 lots, as filed), executed Jun 26.

The name

KYMR

Kymera Therapeutics, Inc. KYMR · Healthcare · 58 filings in 24 months ticker →

Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Bruce Booth in KYMR

KYMRSALE Kymera Therapeutics, Inc. $8.2M
75,750 sh across 12 lots
Exec Jun 29
Filed Jul 2 · 5:39 PM ET † KYMRSALE Kymera Therapeutics, Inc. $3.4M
31,126 sh across 7 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $56.3M
511,764 sh across 27 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $34.5M
283,553 sh across 16 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $43.8M
396,626 sh across 22 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $3.3M
31,798 sh across 4 lots
Exec Jun 22
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $45.1M
476,201 sh across 26 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $531K
5,900 sh × $89.96
Exec Apr 22
Filed Apr 24 · 5:30 PM ET